课题基金 / 基金详情

项目摘要

项目成果

Jack A Elias的其他基金

相似基金

相关文献

中文摘要
翻译
描述(由申请人提供):慢性阻塞性肺疾病(COPD)包括肺气肿和慢性支气管炎。这是一个紧迫的临床问题和一个深刻的未满足的医疗需求。关于肺气肿的发病机制,已经提出了许多理论。“蛋白酶/抗蛋白酶”假说认为,正常肺受到“抗蛋白酶屏障”的保护,肺气肿是由蛋白酶增加和/或抗蛋白酶减少引起的。据推测,COPD中的Th 1炎症是导致这些改变的原因。最近,结构细胞凋亡已被证明在肺气肿。Th 1诱导蛋白酶/抗蛋白酶改变的机制知之甚少。重要的是,Th 1应答诱导肺或其他器官中的组织损伤和破坏的机制也尚未确定。我们的研究表明,香烟烟雾(CS)诱导肺气肿通过IFN-γ依赖的机制和IFN-γ引起肺气肿通过一种新的组织蛋白酶介导的上皮细胞凋亡/DNA损伤(CMEA)途径。他们还证明,CMEA参与了一个正反馈循环,增加炎症和蛋白酶负担。我们推测:(1)IFN-γ在肺气肿的发病机制中起重要作用。(2)IFN-γ通过早期生长反应基因1(Egr-1)诱导的新型CMEA反应以及外源性和内源性凋亡途径诱导肺气肿。(3)CMEA在调节组织炎症和蛋白酶负荷的caspase-11和caspase-1依赖性扩增环中起核心作用。我们将测试这一假设,并解决机制的Th 1诱导的组织破坏与以下目标。目的1:描述IFN-γ系统的改变以及这些改变在CS和IFN-γ诱导的肺气肿的发病机制中的作用。目标二:表征CS暴露小鼠和IFN-γ Tg小鼠中的组织蛋白酶系统反应及其在肺细胞凋亡、损伤和肺气肿发病机制中的作用。目标3:明确Egr-1、外源性和内源性凋亡途径以及终末效应物半胱天冬酶在IFN-γ和CS诱导的肺细胞凋亡、损伤和肺气肿发病机制中的作用。目的4:确定CMEA调节CS暴露和IFN-γ Tg小鼠中炎症和蛋白酶负荷的贡献和机制。
英文摘要
DESCRIPTION (provided by applicant): Chronic obstructive pulmonary disease (COPD) includes emphysema and chronic bronchitis. It is a pressing clinical problem and a profound unmet medical need. A number of theories of emphysema pathogenesis have been proposed. The "protease/ antiprotease" hypothesis contends that the normal lung is protected by an "antiprotease shield" and that emphysema is caused by an increase in proteases and/or a decrease in antiproteases. It has been speculated that the Th1 inflammation in COPD is responsible for these alterations. More recently, structural cell apoptosis has been documented in emphysema. The mechanism(s) of Th1 induction of protease/ antiprotease alterations is poorly understood. Importantly, the mechanism(s) by which Th1 responses induce tissue injury and destruction, in the lung or other organs, have also not been defined. Our studies demonstrate that cigarette smoke (CS) induces emphysema via an IFN-y-dependent mechanism and that IFN-y causes emphysema via a novel cathepsin-mediated epithelial cell apoptosis/DNA injury (CMEA) pathway. They also demonstrated that CMEA participates in a positive feedback loop that augments inflammation and protease burden. We hypothesize that: (1) IFN-y plays a critical role in the pathogenesis of pulmonary emphysema. (2) IFN-y induces emphysema via a novel CMEA response that is induced by early growth response gene 1 (Egr-1) and the extrinsic and intrinsic apoptosis pathways. (3) CMEA plays a central role in a caspase-11 and caspase-1-dependent amplification loop that regulates tissue inflammation and protease burden. We will test this hypothesis and address the mechanisms of-Th1-induced tissue destruction with the following aims. Aim 1: Characterize the alterations in the IFN-y system and the role(s) of these alterations in the pathogenesis of CS and IFN-y-induced emphysema. Aim 2: Characterize the cathepsin system responses in CS-exposed and IFN-y Tg mice and their role(s) in the pathogenesis of pulmonary apoptosis, injury and emphysema. Aim 3: Define the roles of Egr-1, the extrinsic and intrinsic apoptosis pathways and terminal effector caspases in the pathogenesis of IFN-y and CS-Induced pulmonary apoptosis, injury and emphysema. Aim 4: Define the contribution of and mechanism by which CMEA regulates inflammation and protease burden in CS-exposed and IFN-y Tg mice.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Differential Roles of Chi3l1 and its receptors in COPD and IPF
Differential Roles of Chi3l1 and its receptors in COPD and IPF
YKL-40 in Idiopathic Pulmonary Fibrosis and Kidney Transplantation
  • 批准号:
    8499409
  • 项目类别:
  • 资助金额:
    $62.22万
  • 财政年份:
    2011
  • 负责人:
    Jack A Elias
  • 依托单位:
YKL-40 in Idiopathic Pulmonary Fibrosis and Kidney Transplantation
  • 批准号:
    8818109
  • 项目类别:
  • 资助金额:
    $63.38万
  • 财政年份:
    2011
  • 负责人:
    Jack A Elias
  • 依托单位:
国内基金
海外基金
Epac1/2通过蛋白酶体调控中性粒细胞NETosis和Apoptosis在急性肺损伤中的作用研究
  • 批准号:
    LBY21H010001
  • 项目类别:
    省市级项目
  • 资助金额:
    --
  • 批准年份:
    2020
  • 负责人:
    郑绪阳
  • 依托单位:
基于Apoptosis/Ferroptosis双重激活效应的天然产物AlbiziabiosideA的抗肿瘤作用机制研究及其结构改造
  • 批准号:
    81703335
  • 项目类别:
    青年科学基金项目
  • 资助金额:
    20.0万元
  • 批准年份:
    2017
  • 负责人:
    卫高菲
  • 依托单位:
双肝移植后Apoptosis和pyroptosis在移植物萎缩差异中的作用和供受者免疫微环境变化研究
  • 批准号:
    81670594
  • 项目类别:
    面上项目
  • 资助金额:
    58.0万元
  • 批准年份:
    2016
  • 负责人:
    陈昊
  • 依托单位:
Serp-2 调控apoptosis和pyroptosis 对肝脏缺血再灌注损伤的保护作用研究
  • 批准号:
    81470791
  • 项目类别:
    面上项目
  • 资助金额:
    73.0万元
  • 批准年份:
    2014
  • 负责人:
    董家鸿
  • 依托单位: